AVICANNA and EI Ventures Enters in Agreement to Develop and Commercialize Adaptogen Nutraceuticals

July 4, 2022 0 Comments

AVICANNA AND EI. VENTURES ENTER INTO AN AGREEMENT TO DEVELOP AND COMMERCIALIZE ADAPTOGEN NUTRACEUTICALS Avicanna Inc. has entered into an intellectual property licensing and royalty agreement (IPLRA) with Ei.Ventures Inc. to develop and commercialize functional fungi-based products. “Over the past six years our team established a scientific platform that has led to the commercialization of […]